Melinta Therapeutics
KIMYRSA
Manufacturer:
Melinta Therapeutics
Name:
KIMYRSA
HCPCS Code Descriptor:
Injection, oritavancin (kimyrsa), 10 mg
Category:
J Code
HCPCS:
J2406
NDC(s):
70842-0225-01
Primary Type:
Antibiotic
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
KIMYRSA is an Antibiotic drug manufactured by Melinta Therapeutics and administered via the Intravenous route of administration. The J Code: J2406 is aligned to the drug KIMYRSA.
Access Pricing and More By Registering
HCPCS Added Date:
10/1/21
HCPCS Effective Date:
10/1/21
HCPCS Short Description:
Injection, oritavancin 10 mg
Billing and Coding Guide:
https://kimyrsa.com/wp-content/uploads/2022/04/PP-KIM-US-0148-KIMYRSA-2022-Billing-and-Coding-Guide.pdf
Patient Assistance:
https://kimyrsa.com/support-programs/